Objective: To examine racial disparities in the in-hospital utilization of frequently performed prophylactic vaccinations and inoculations in the U.S. Methods: Using 2011 Nationwide Inpatient Sample (NIS) data…
vaccine development. Such approaches have utilized mRNA for both therapeutic cancer vaccinations, and for prophylactic vaccines, drawing much attention from industrial and academic fields. RNActive®, an mRNA based…
growth, and markedly prolonged survival of EOC bearing mice in the prophylactic setting compared with non-CSC vaccination. Flow cytometry showed significantly increased immunocyte cytotoxicities and remarkablely reduced…
coli only; 1 grew E. coli, and enterocci; and 1 grew no organisms. Prophylactic vaccination with clostridial toxoids proved effectiveness in preventing anaerobic infection, and reduce mortality in rats that ... pilot…
vaccine efficacy was 49%. The vaccine was safe and well tolerated. Thus, prophylactic administration of quadrivalent HPV vaccine is effective in preventing high-grade VIN/VaIN, suggesting that such vaccination
results forecast a favorable outcome of the Phase II trial. This killed whole-HIV vaccine is a unique approach in HIV vaccinology. This approach will present the native structural proteins ... hepatitis A, and more than…
VP13/14 (UL47) were evaluated as vaccine candidates. The plasmid DNAs were formulated with Vaxfectin?, a patented cationic liposome adjuvant. Prophylactically, the Vaxfectin?-formulated plasmid DNAs protected against…
iven the important role of adjuvants in prophylactic vaccines as well as tumor immunotherapy, identification and development of new adjuvants with enhanced efficacy and safety is necessary. CureVac has recently…
espite the existence of effective prophylactic vaccines, hepatitis B virus (HBV) infections remain a major public health problem. About 370 million people are chronically infected worldwide. Chronic hepatitis…
progressive and develops cirrhosis of the liver and hepatocellular carcinoma. Although potent prophylactic vaccines against HBV have been developed and commercialized for more than 4 decades, still several million
Background: Prophylactic human papilloma virus (HPV) vaccines represent a promising option for cervical cancer (CC) prevention in countries where screening, diagnostics and treatment have difficulties in producing…
first prophylactic Virus-like Particle (VLP) based Human Papillomavirus (HPV) vaccine was registered for use nearly 13 year now. WHO already released an updated position paper ... accurate and comparable methods for…
smallpox. Jenner's work is widely regarded as the foundation of prophylactic measure of disease by the vaccine, the term derived from "Vacca” means cow. The concept of the vaccine
hile the guideline of non-clinical studies for prophylactic vaccines against infectious diseases was publicized in 2010, the one for therapeutic vaccines has yet to be established in Japan ... clinical studies that are…